$STRO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SUTRO BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SUTRO BIOPHARMA, INC.. Get notifications about new insider transactions in SUTRO BIOPHARMA, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 20 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Pres. Rsrch & Cf. S ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Apr 20 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Pres. Rsrch & Cf. S ... | Option Exercise | A | 20.01 | 20,000 | 400,200 | 20,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | A | 21.11 | 200,000 | 4,222,000 | 200,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | A | 21.11 | 60,000 | 1,266,600 | 60,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | A | 21.11 | 60,000 | 1,266,600 | 60,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | A | 21.11 | 50,000 | 1,055,500 | 50,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | A | 21.11 | 50,000 | 1,055,500 | 50,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Mar 08 2021 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | A | 21.11 | 50,000 | 1,055,500 | 50,000 | |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | M | 0.00 | 13,750 | 0 | 41,250 | |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Payment of Exercise | F | 22.15 | 7,061 | 156,401 | 185,349 | 192.4 K to 185.3 K (-3.67 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Buy | M | 0.00 | 13,750 | 0 | 192,410 | 178.7 K to 192.4 K (+7.70 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | M | 0.00 | 5,250 | 0 | 15,750 | |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Payment of Exercise | F | 22.15 | 2,107 | 46,670 | 20,859 | 23 K to 20.9 K (-9.17 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Buy | M | 0.00 | 5,250 | 0 | 22,966 | 17.7 K to 23 K (+29.63 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 0.00 | 5,250 | 0 | 15,750 | |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Payment of Exercise | F | 22.15 | 2,080 | 46,072 | 59,287 | 61.4 K to 59.3 K (-3.39 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 0.00 | 5,250 | 0 | 61,367 | 56.1 K to 61.4 K (+9.36 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | M | 0.00 | 8,250 | 0 | 24,750 | |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Payment of Exercise | F | 22.15 | 3,147 | 69,706 | 20,719 | 23.9 K to 20.7 K (-13.19 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | M | 0.00 | 8,250 | 0 | 23,866 | 15.6 K to 23.9 K (+52.83 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | M | 0.00 | 4,500 | 0 | 13,500 | |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Payment of Exercise | F | 22.15 | 1,845 | 40,867 | 13,920 | 15.8 K to 13.9 K (-11.70 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Buy | M | 0.00 | 4,500 | 0 | 15,765 | 11.3 K to 15.8 K (+39.95 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | M | 0.00 | 5,250 | 0 | 15,750 | |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Payment of Exercise | F | 22.15 | 2,126 | 47,091 | 14,200 | 16.3 K to 14.2 K (-13.02 %) |
Feb 01 2021 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Buy | M | 0.00 | 5,250 | 0 | 16,326 | 11.1 K to 16.3 K (+47.40 %) |
Jan 27 2021 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Option Exercise | M | 4.36 | 4,132 | 18,016 | 0 | |
Jan 27 2021 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Buy | M | 4.36 | 4,132 | 18,016 | 7,988 | 3.9 K to 8 K (+107.16 %) |
Jan 27 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 4.36 | 2,393 | 10,433 | 4 | |
Jan 27 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Sell | S | 26.10 | 165 | 4,306 | 56,117 | 56.3 K to 56.1 K (-0.29 %) |
Jan 27 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Sell | S | 25.68 | 2,228 | 57,222 | 56,282 | 58.5 K to 56.3 K (-3.81 %) |
Jan 27 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 4.36 | 2,393 | 10,433 | 58,510 | 56.1 K to 58.5 K (+4.26 %) |
Jan 20 2021 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | M | 4.36 | 1,652 | 7,203 | 0 | |
Jan 20 2021 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | M | 4.36 | 1,652 | 7,203 | 15,616 | 14 K to 15.6 K (+11.83 %) |
Jan 15 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 4.36 | 19,405 | 84,606 | 0 | |
Jan 15 2021 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 4.36 | 19,405 | 84,606 | 56,117 | 36.7 K to 56.1 K (+52.86 %) |
Dec 29 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 4.36 | 2,393 | 10,433 | 2,397 | |
Dec 29 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Sell | S | 22.37 | 2,393 | 53,530 | 36,712 | 39.1 K to 36.7 K (-6.12 %) |
Dec 29 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 4.36 | 2,393 | 10,433 | 39,105 | 36.7 K to 39.1 K (+6.52 %) |
Dec 14 2020 | STRO | SUTRO BIOPHARMA, I ... | Freund John Gordon | Director | Buy | J | 0.00 | 56,327 | 0 | 56,327 | 0 to 56.3 K |
Dec 14 2020 | STRO | SUTRO BIOPHARMA, I ... | Freund John Gordon | Director | Sell | J | 0.00 | 118,735 | 0 | 0 | 118.7 K to 0 (-100.00 %) |
Dec 01 2020 | STRO | SUTRO BIOPHARMA, I ... | Wigginton Jon Marc | Director | Option Exercise | A | 17.10 | 24,000 | 410,400 | 24,000 | |
Nov 30 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 4.36 | 2,393 | 10,433 | 4,790 | |
Nov 30 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Sell | S | 17.01 | 2,393 | 40,713 | 36,712 | 39.1 K to 36.7 K (-6.12 %) |
Nov 30 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 4.36 | 2,393 | 10,433 | 39,105 | 36.7 K to 39.1 K (+6.52 %) |
Nov 06 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 4.36 | 16,751 | 73,034 | 7,183 | |
Nov 06 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Sell | S | 15.00 | 16,751 | 251,265 | 36,712 | 53.5 K to 36.7 K (-31.33 %) |
Nov 06 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 4.36 | 16,751 | 73,034 | 53,463 | 36.7 K to 53.5 K (+45.63 %) |
Oct 06 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 4.36 | 9,182 | 40,034 | 23,934 | |
Oct 06 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 4.36 | 9,182 | 40,034 | 36,712 | 27.5 K to 36.7 K (+33.35 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | M | 0.00 | 25,252 | 0 | 25,253 | |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Payment of Exercise | F | 10.30 | 13,219 | 136,156 | 178,660 | 191.9 K to 178.7 K (-6.89 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Buy | M | 0.00 | 25,252 | 0 | 191,879 | 166.6 K to 191.9 K (+15.15 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | M | 0.00 | 8,609 | 0 | 8,609 | |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Payment of Exercise | F | 10.30 | 2,976 | 30,653 | 17,716 | 20.7 K to 17.7 K (-14.38 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Buy | M | 0.00 | 8,609 | 0 | 20,692 | 12.1 K to 20.7 K (+71.25 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 0.00 | 6,887 | 0 | 0 | |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Option Exercise | M | 0.00 | 11,019 | 0 | 11,019 | |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Sell | S | 10.26 | 975 | 10,007 | 27,530 | 28.5 K to 27.5 K (-3.42 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Payment of Exercise | F | 10.30 | 2,381 | 24,524 | 28,505 | 30.9 K to 28.5 K (-7.71 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 0.00 | 6,887 | 0 | 30,886 | 24 K to 30.9 K (+28.70 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Payment of Exercise | F | 10.30 | 3,810 | 39,243 | 23,999 | 27.8 K to 24 K (-13.70 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Buy | M | 0.00 | 11,019 | 0 | 27,809 | 16.8 K to 27.8 K (+65.63 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | M | 0.00 | 7,576 | 0 | 7,576 | |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Payment of Exercise | F | 10.30 | 2,619 | 26,976 | 13,964 | 16.6 K to 14 K (-15.79 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | M | 0.00 | 7,576 | 0 | 16,583 | 9 K to 16.6 K (+84.11 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | M | 0.00 | 8,609 | 0 | 8,609 | |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Payment of Exercise | F | 10.30 | 2,976 | 30,653 | 11,265 | 14.2 K to 11.3 K (-20.90 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Buy | M | 0.00 | 8,609 | 0 | 14,241 | 5.6 K to 14.2 K (+152.86 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | M | 0.00 | 7,174 | 0 | 7,174 | |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Payment of Exercise | F | 10.30 | 2,480 | 25,544 | 11,076 | 13.6 K to 11.1 K (-18.29 %) |
Sep 28 2020 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Buy | M | 0.00 | 7,174 | 0 | 13,556 | 6.4 K to 13.6 K (+112.41 %) |
Sep 22 2020 | STRO | SUTRO BIOPHARMA, I ... | Freund John Gordon | Director | Sell | S | 12.00 | 400,000 | 4,800,000 | 560,053 | 960.1 K to 560.1 K (-41.66 %) |
Sep 15 2020 | STRO | SUTRO BIOPHARMA, I ... | Freund John Gordon | Director | Sell | S | 10.00 | 500,000 | 5,000,000 | 960,053 | 1.5 M to 960.1 K (-34.25 %) |
Aug 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Scientific Of ... | Sell | S | 9.04 | 975 | 8,818 | 16,790 | 17.8 K to 16.8 K (-5.49 %) |
Aug 21 2020 | STRO | SUTRO BIOPHARMA, I ... | Freund John Gordon | Director | Sell | S | 8.72 | 500,000 | 4,360,000 | 1,460,053 | 2 M to 1.5 M (-25.51 %) |
Jul 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 8.06 | 975 | 7,858 | 17,765 | 18.7 K to 17.8 K (-5.20 %) |
Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | PANEK JAMES P | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | Sharp Shalini | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | MATSUI CONNIE | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | Lobacki Joseph M | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | Freund John Gordon | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | Dybbs Michael | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
May 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 10.00 | 975 | 9,753 | 19,715 | 20.7 K to 19.7 K (-4.71 %) |
May 14 2020 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Buy | P | 7.75 | 64,516 | 499,999 | 166,627 | 102.1 K to 166.6 K (+63.18 %) |
May 14 2020 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Buy | P | 7.75 | 6,451 | 49,995 | 12,083 | 5.6 K to 12.1 K (+114.54 %) |
May 14 2020 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | P | 7.75 | 3,225 | 24,994 | 9,007 | 5.8 K to 9 K (+55.78 %) |
Apr 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 11.19 | 2 | 22 | 20,690 | 20.7 K to 20.7 K (-0.01 %) |
Apr 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 11.19 | 2 | 22 | 20,690 | 20.7 K to 20.7 K (-0.01 %) |
Apr 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 9.41 | 973 | 9,161 | 20,692 | 21.7 K to 20.7 K (-4.49 %) |
Apr 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 9.41 | 973 | 9,161 | 20,692 | 21.7 K to 20.7 K (-4.49 %) |
Mar 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 9.69 | 975 | 9,453 | 21,665 | 22.6 K to 21.7 K (-4.31 %) |
Feb 27 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 10.47 | 975 | 10,207 | 22,640 | 23.6 K to 22.6 K (-4.13 %) |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | A | 0.00 | 55,000 | 0 | 55,000 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | A | 10.09 | 125,000 | 1,261,250 | 125,000 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | A | 0.00 | 21,000 | 0 | 21,000 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | A | 10.09 | 47,500 | 479,275 | 47,500 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Option Exercise | A | 0.00 | 21,000 | 0 | 21,000 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Option Exercise | A | 10.09 | 47,500 | 479,275 | 47,500 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | A | 0.00 | 33,000 | 0 | 33,000 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | A | 10.09 | 66,250 | 668,463 | 66,250 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | A | 10.09 | 41,250 | 416,213 | 41,250 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | A | 0.00 | 21,000 | 0 | 21,000 | |
Jan 31 2020 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | A | 10.09 | 47,500 | 479,275 | 47,500 | |
Jan 28 2020 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 10.51 | 975 | 10,250 | 23,615 | 24.6 K to 23.6 K (-3.97 %) |
Jan 08 2020 | STRO | SUTRO BIOPHARMA, I ... | PANEK JAMES P | Director | Option Exercise | A | 12.02 | 24,000 | 288,480 | 24,000 | |
Dec 27 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 11.08 | 975 | 10,802 | 24,590 | 25.6 K to 24.6 K (-3.81 %) |
Nov 27 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 10.68 | 975 | 10,410 | 25,565 | 26.5 K to 25.6 K (-3.67 %) |
Oct 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 9.98 | 975 | 9,726 | 26,540 | 27.5 K to 26.5 K (-3.54 %) |
Oct 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Sell | S | 9.98 | 975 | 9,726 | 26,540 | 27.5 K to 26.5 K (-3.54 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | M | 0.00 | 25,252 | 0 | 50,505 | |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Payment of Exercise | F | 9.74 | 13,219 | 128,753 | 106,118 | 119.3 K to 106.1 K (-11.08 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Buy | M | 0.00 | 25,252 | 0 | 119,337 | 94.1 K to 119.3 K (+26.84 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | M | 0.00 | 8,608 | 0 | 17,218 | |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Payment of Exercise | F | 9.74 | 2,976 | 28,986 | 5,632 | 8.6 K to 5.6 K (-34.57 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Buy | M | 0.00 | 8,608 | 0 | 8,608 | 0 to 8.6 K |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Option Exercise | M | 0.00 | 6,887 | 0 | 6,887 | |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Option Exercise | M | 0.00 | 11,019 | 0 | 22,038 | |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Payment of Exercise | F | 9.74 | 2,381 | 23,191 | 27,515 | 29.9 K to 27.5 K (-7.96 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Buy | M | 0.00 | 6,887 | 0 | 29,896 | 23 K to 29.9 K (+29.93 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Payment of Exercise | F | 9.74 | 3,810 | 37,109 | 23,009 | 26.8 K to 23 K (-14.21 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Buy | M | 0.00 | 11,019 | 0 | 26,819 | 15.8 K to 26.8 K (+69.74 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | M | 0.00 | 7,575 | 0 | 15,152 | |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Payment of Exercise | F | 9.74 | 2,619 | 25,509 | 5,782 | 8.4 K to 5.8 K (-31.17 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | M | 0.00 | 7,575 | 0 | 8,401 | 826 to 8.4 K (+917.07 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | M | 0.00 | 8,608 | 0 | 17,218 | |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Payment of Exercise | F | 9.74 | 2,976 | 28,986 | 5,632 | 8.6 K to 5.6 K (-34.57 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Buy | M | 0.00 | 8,608 | 0 | 8,608 | 0 to 8.6 K |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | M | 0.00 | 7,174 | 0 | 14,348 | |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Payment of Exercise | F | 9.74 | 2,480 | 24,155 | 6,382 | 8.9 K to 6.4 K (-27.98 %) |
Sep 30 2019 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Buy | M | 0.00 | 7,174 | 0 | 8,862 | 1.7 K to 8.9 K (+425.00 %) |
Sep 06 2019 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Option Exercise | M | 5.09 | 826 | 4,204 | 0 | |
Sep 06 2019 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Option Exercise | M | 5.09 | 826 | 4,204 | 0 | |
Sep 06 2019 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Buy | M | 5.09 | 826 | 4,204 | 3,856 | 3 K to 3.9 K (+27.26 %) |
Sep 06 2019 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Buy | M | 5.09 | 826 | 4,204 | 3,856 | 3 K to 3.9 K (+27.26 %) |
Aug 29 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | M | 5.09 | 826 | 4,204 | 0 | |
Aug 29 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | M | 5.09 | 826 | 4,204 | 826 | 0 to 826 |
Aug 29 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | M | 5.09 | 826 | 4,204 | 0 | |
Aug 29 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | M | 5.09 | 826 | 4,204 | 826 | 0 to 826 |
Jun 26 2019 | STRO | SUTRO BIOPHARMA, I ... | MATSUI CONNIE | Director | Option Exercise | A | 11.68 | 23,076 | 269,528 | 23,076 | |
Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | Sharp Shalini | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 | |
Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | Petree Daniel H | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 |